Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 1Phase 3 1Phase 1/2 1Phase 1 1

Status

Recruiting 23Active not recruiting 12Completed 8Not yet recruiting 7Unknown 6Terminated 5Withdrawn 4

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Prostatic Neoplasms 5

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 144Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Androgen Antagonists × Clear all
NCT05676463 2026-03-03

MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer

Thomas Jefferson University

Phase 2 Terminated
6 enrolled
Genitourinary

Prostatic Neoplasms

NCT04298983 2025-03-19

RAD 1805

University of Alabama at Birmingham

Phase 2 Terminated
9 enrolled 8 charts
Genitourinary

Prostatic Neoplasms

NCT03649841 2023-10-26

Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer

University of Washington

Phase 2 Terminated
10 enrolled 7 charts
Genitourinary

Prostatic Neoplasms

NCT03827473 2020-06-25

ACADEMIC

University of Utah

Phase 2 Terminated
1 enrolled 6 charts
Genitourinary

Prostatic Neoplasms

NCT00521781 2016-03-17

Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer

The Methodist Hospital Research Institute

Phase 2 Terminated
14 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡